Redeye updates its view on Flexion Mobile following its strong Q3 2022 report released on November 2...
Ultimovacs has announced that the Phase II LUNGVAC study (NCT05344209) will be switching the immune ...
Redeye has updated estimates and valuation on GiG after the announced acquisitoin of Askgamblers whi...
Atria records EUR 51m impairments in Sweden. High inflation affecting consumer behaviour, the exit o...
UBConnect adderar ca 20% till försäljningen Transtema har annonserat att de har tecknat avtal att kö...
Analysguiden inleder bevakning av medicinteknikbolaget Prostatype med motiverat värde 3,7-6,1 kr.
Yesterday, BankNordik adjusted its 2022 net profit guidance upwards, from DKK 140-170m to DKK 160-19...
Redeye gives a short comment on today’s news of a directed issue in Annexin, where the proceeds will...
Redeye is optimistic about the safety data reported by Amniotics yesterday, which we comment in this...
Toleranzia går in i slutskedet av de prekliniska studierna för TOL2, mot Myastenia Gravis.
On Monday morning BankNordik upgraded its net profit guidance for 2022 back to DKK 160-190m which wa...
CirChem meddelade den 16 december att de ingått ett nytt femårigt ramavtal med Titab Pac för leveran...
Förvärvar Ask Gamblers GIG har ingått avtal med Catena Media om att förvärva tillgångarna AskGambler...
Analysguiden inleder bevakning av den svenska spelutvecklaren med en efterlängtad spellansering i pi...
Redeye updates its estimates for Q4 2022e due to the new Freemelt ONE order from a university in Ger...
Background on guidance upgrade During the week, Urb-it announced a few last-mile delivery partnershi...
Redeye updates its view of Egetis following a change of lead analyst and an eventful year, including...
Redeye comments on Velvet Cichlid's offer to buy Sleep Cycle in a cash deal.
Today, Elanders announced that it implements structural measures regarding non-profitable parts of t...
The final documentation in patent litigation 879 against Apple and Samsung is now public.
